Long Term Antibiotic Therapy on Exacerbation frequency in Stable COPD

• Research type

  Research Study

• Full title

  A Phase III double-blind, randomised, placebo controlled trial of long term therapy on Exacerbation Rate in patients with stable COPD using Moxifloxacin, Azithromyin, or Doxycycline (delete as appropriate)

• IRAS ID

  108511

• Contact name

  Jadwiga Wedzicha

• Contact email

  j.wedzicha@imperial.ac.uk

• Sponsor organisation

  Imperial College Healthcare NHS Trust

• Eudract number

  2012-002199-15

• ISRCTN Number

  n/a

• REC name

  London - Hampstead Research Ethics Committee

• REC reference

  13/LO/0815

• Date of REC Opinion

  25 Jul 2013

• REC opinion

  Further Information Favourable Opinion